Answer all your burning questions (and your patients’ burning questions) about the different COVID-19 vaccines currently authorized in the US. Infectious diseases / HIV expert, Dr Monica Gandhi @MonicaGandhi9 (UCSF) joins us to cover: the Pfizer-BioNTech and Moderna novel mRNA vaccine mechanisms, trial data, and practicalities of who should receive them. We discuss data around the Oxford-AstraZeneca adenovirus vaccine, which is authorized in the UK and India, and may be available in the US later this year. Feel confident recommending COVID-19 vaccines to your patients!
Episodes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | [email protected] | Free CME!
Credits
Written and Produced by: Molly Heublein, MDCover Art: Chris Chiu, MD, FACP, FAAPInfographic: Tima KarginovHosts: Chris Chiu, MD, FACP, FAAP; Molly Heublein, MD; Paul Williams, MD, FACPEditor: Emi Okamoto MD (written materials); Clair Morgan of Nodderly.com (audio)Guest: Monica Gandhi, MD, MPH
Sponsor: Panacea Financial
This episode is supported by Panacea Financial, digital banking built for doctors, by doctors. At Panacea Financial you can have your own free personal banker and a support team that works around the clock- just like you do. Open your free checking account today at panaceafinancial.com
Panacea Financial, a Division of Sonabank, Member FDIC
Sponsor: VCU Health CE
The Curbsiders are partnering with VCU Health Continuing Education to offer FREE continuing education credits for physicians and other healthcare professionals. Visit curbsiders.vcuhealth.org.
Time Stamps
Intro, disclaimer, guest bio - 00:00 Guest one-liner, book recommendation - 3:40
Authorized vaccines in the US - 8:30AstraZeneca vaccine mechanism- 9:26mRNA vaccine mechanism - 10:30Vaccine distribution issues (cold chain) - 16:05mRNA safety - 18:24mRNA vaccine efficacy/data from phase 3 trials - 19:40How did we get this so quickly - 23:40Vaccine impact on asymptomatic infection - 26:18AstraZeneca trials - 28:20Pregnancy - 35:10Anaphylaxis - 37:10Prior COVID-19 infection - 39:07Side effects - 42:05Pediatric patients - 45:12Phases of role outs in the US -46:50Herd immunity - 48:16Thoughts of how to make this happen - 52:45Preexisting conditions - 53:40How long will immunity last - 57:15Mutant strains - 58:25Future of mRNA vaccines - 1:00:30Take home points and Outro - 1:02:12